genetic disease 2 Flashcards

1
Q

describe Alkaptonuria (ochronosis)

A
  • Autosomal recessive
  • Deficiency of HOMOGENTISIC ACID OXIDASE
  • causes Homogentisic acid accumulates as blue/black pigment which binds to collagen in connective tissue/tendons/cartilage
  • Excreted in urine –> urine turns BLACK if allowed to stand and oxidize, or upon adding alkali
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe degenerative arthropathy

A
  • HOMOGENTISIC acid deposits in CARTILAGE of ARTICULAR SURFACES which turns to brittle and flakes
  • occurs in INTERVERTEBRAL DISCS, and later in knees, hips, shoulders
  • small joints are speared
  • may be crippling (severe osteoarthritis that occurs earlier in age)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe lysosomal storage disease

A
  • autosomal recessive
  • Failure of catabolism of large molecules WITHIN lysosomes due to lack of enzymes (various kinds), mutant inactive enzymes etc
  • can be put on enzyme replacement therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe Tay-Sachs disease

A
  • Gangliosidase deficiency due to FRAMESHIFT mutation in HexA gene
  • LACK of HEXOSAMINIDASE A leading to accumulaation of GM2ganglioside
  • often found in Ashkenazi Jew population
  • Ballooning of neurons (membranous concentric bodies)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the features of Tay Sach’s diseaase

A

TAYSACHS

  • Testing recommended
  • autosomal recessive
  • Young death (4 years)
  • Spot of Macula (cherry red spots)
  • Ashkenazi jews
  • CNS degeneration
  • Hex A deficiency
  • Storage disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe Cherry red spots

A
  • Cherry red spot on the Macula (spot is normal color, but the rest of retina is TOO WHITE due to lipid accumulation)
  • produced when ganglion cells (filled with lipid) degenerate, exposing the vascular choroidal tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define Amaurotic idiocy

A
  • blindness (amaurosis) produced by retinal involvement, together with the mental deterioration produced by destruction of other neurons has given the disease the name amaurotic idiocy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe Gaucher disease

A
  • Autosomal recessive
  • mutation in gene encoding enzyme Beta-Glucocerebrosidase (GBA) which functions in breaking down glucocerebroside into glucose and a fat called ceramide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mononuclear phagocyte system

A
  • defect leads to accumulation of GLUCOSYLCERAMIDE in macrophages of the reticuloendothelial system (RES) and their subsequent enlargements
  • Gaucher cells form
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Define Gaucher cells

A
  • Huge macrophages (bloated) with glucocerebroside
  • -> accumulates mostly in spleen, liver and bone marrow
  • cells appear like “weingkled tissue paper” or “crinkled cigarette paper”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe The types of Guacher Disease

A
  • 3 Types:
  • -> Type I = adult type, common in ashkenazi jews and is NON-NEURONOPATHIC (compatible with long life)
  • -> Type II and III = rare but NEURONOPATHIC (II is most severe)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the clincial characteristics of Guachers disease

A
  • massively enlarged spleen
  • large liver and lymph nodes
  • Skeletal problems = excruciating bone pain and fractures due to marrow being packed with ever-expanding cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the clincial characteristics of Guachers disease

A
  • massively enlarged spleen
  • large liver and lymph nodes
  • Skeletal problems = excruciating bone pain and fractures due to marrow being packed with ever-expanding cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe Type A niemann-Pick disease

A
  • MISSENSE MUTATION with almost total deficiency of the SPHINGOMYELINASE leading to SEVERE accumulation of SPHINGOMYELIN and CHolesterl in lysosome
  • -> results in foamy (vacuolated) cytoplasm (engorged lysosomes on EM with concentric lamellated myeling figures known as ZEBRA BODIES)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe Type C niemann-pick disease

A
  • deficiency in cholesterol transport
  • not an enzyme defect
  • NPC1 and NPC2 gene mutations causing a defect in NONenzymatic lipid transport leading to accumulation of GM gangliosides (and free cholesterol) in lysosomes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe the characteristics of Type A niemann-pick disease

A
  • severe deficiency of sphingomyelinase
  • accumulation of sphingomyelin
  • occurs in infants with early death (3 years
  • -* Neurologic signs = shrunkin gyri/widened sulci (cell death), retinal cherry red spot (like Tay-sachs)
    • Splenomegaly
  • hepatomegaly
  • enlarged lymph nodes
17
Q

describe the characteristics of Type B niemann-pick disease

A
  • sphingomyelinase deficiency
  • survive into adulthood
  • large livers and spleen
  • NO CNS invovlement
18
Q

describe the characteristics of Type C niemann-pick disease

A
  • Hydrops fetalis/ still birth
  • neonatal hepatitis
  • Chronic progressive NEUROLOGICAL DAMAGE
  • most common presentation in childhood = ataxia, vertical supranuclear gaze palsy, dystonia, dysarthria, psychomotor deterioration
19
Q

Describe MucoPolySaccharidoses (MPS)

A
  • deficient Lysosomal enzymes that degrade MUCOPOLYSACCHARIDES (cleave terminal sugars)
  • MPS accumulates in lysosomes of RES and smooth muscles
20
Q

Describe MucoPolySaccharidoses (MPS)

A
  • deficient Lysosomal enzymes that degrade GLYCOSAMINOGLYCANS (GAGs) leads to accumulation in tissues
  • CLINICAL FEATURES = skeletal abnormalties, corneal clouding, organomegaly, joint stiffness, hermias, short stature, mental retardation
  • Vacuolated lymphocytes in peripheral smear and excessive urinary GAGs are typical findings
21
Q

describe Hurler syndrome (MPS IH)

A
  • Autosomal recessive

- Deficiency in alpha-L-IDURONIDASE results in accumulation of DERMATAN SULFATE and HEPARAN SULFATE

22
Q

describe the clinical manifestations of HURLER SYNDROME (MPS IH)

A
  • affected individual appear normal at birth
  • exhibit accelerated growth in first year followed by slowing of growth leading to short stature
  • first 2 years, hepatosplenomegaly, corneal clouding, coarse facial features, large tongue, joint stiffness and characteristic skeletal abnormalities develop
  • progressive mental retardation, skeletal malformations and cardiopulmonary compromise typically lead to death during the first decade
23
Q

describe Hunter syndrome (MPS II)

A
  • deficiency in IDURONOSULFATE SULFATASE
  • clinically is similar to MPS IH
  • -> NO corneal clouding
  • -> symptoms range from severe CNS and visceral involvement with death to normal CNS function and survival into adulthood
24
Q

describe glycogen storage diseases

A
  • disorders affecting the synthesis or degradation of glycogen
  • characterized by abnormal deposits of glycogen in tissues
  • Autosomal recessive
  • GSD typically cause fasting hypoglycemia and hepatomegaly
25
Q

describe Type I GSD (Von Gierke disease

A
  • Defect in Hepatic Glucose-6-phosphatase or glucose-6-phosphatase translocase which leads to inadequate conversion of glucose-6-phosphate to glucose
  • accumulation of glycogen in liver and renal tubules and hypoglycemia
26
Q

describe clinical features of Type I GSD (Von Gierke disease)

A
  • enlarged liver, and kidney
  • hypoglycemia, lactic acidosis
  • hyperlipidemia and hyperuricemia
  • LATE COMPLICATIONS = hepatic adenomas and renal failure
  • Maintenance of blood glucose concentration with physiologic ranges allows favorable development
27
Q

describe Type V GSD (McArdle disease)

A
  • lack of muscle phosphorylase limits ATP generation by glycogenolysis and results in glycogen accumulation
  • diagnosis is indicated by ELEVATION in SERUM muscle CREATINE KINASE acivity and failure to increase lactate level with exercise
  • confirmed on elevated muscle glycogen and reduced phosphorylase activity
28
Q

describe the clinical features of Type V GSD

A

-

29
Q

describe Type I GSD (Von Gierke disease

A
  • Defect in HEPATIC Glucose-6-phosphatase or glucose-6-phosphatase translocase which leads to inadequate conversion of glucose-6-phosphate to glucose
  • accumulation of glycogen in liver and renal tubules and hypoglycemia
30
Q

describe Type V GSD (McArdle disease)

A
  • lack of MUSCLE phosphorylase limits ATP generation by glycogenolysis and results in glycogen accumulation
  • diagnosis is indicated by ELEVATION in SERUM muscle CREATINE KINASE acivity and failure to increase lactate level with exercise
  • confirmed on elevated muscle glycogen and reduced phosphorylase activity
31
Q

describe the clinical features of Type V GSD

A
  • Excercise intolerance with muscle cramps and myoglobinuria (secondary to rhabdomyolysis)
  • develop in late childhood or as an adult
  • Intense myoglobinuria may cause ACUTE RENAL FAILURE
32
Q

describe Type II GSD (pompe disease)

A
  • deficiency of ACID-ALPHA-1,4-GLUCOSIDASE (acid maltase) results in lysosomal accumulation of glycogen in heart, muscle, liver, and nervous system
  • Diagnosis is based on deficient enzyme activity in muscle, fibroblasts, amniotic cells or CVS and identifcation of mutations (SYSTEMIC)
33
Q

describe the clinical features of Pompe disease

A
  • infantile-onset form features cardiomegaly, HYPOTONIA and death prior to 2 years of age
  • Juvenile form presents as difficult walking in childhood followed by swallowing difficulties and muscle weakness
  • -> death from respiratory failure may occur before the end of 2nd decade
  • Adult form is slowly progressive muscle weakness with respiratory insufficiency